CNS Research, Inc.   Report issue

For profit Phase 2
Founded: East Providence RI United States (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
2007
NCT00633321
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

CNS Research Institute, P.C

Active Ingredients

Drugs in Phase 2 Trials (2)

loxapine (loxitane) (1 trial)

ta-nic (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Headache (Phase 2)

Migraine Disorders (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2